These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161 [TBL] [Abstract][Full Text] [Related]
23. Allovectin-7 therapy in metastatic melanoma. Bedikian AY; Del Vecchio M Expert Opin Biol Ther; 2008 Jun; 8(6):839-44. PubMed ID: 18476795 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma. Doukas J; Rolland A Cancer Gene Ther; 2012 Dec; 19(12):811-7. PubMed ID: 23037806 [TBL] [Abstract][Full Text] [Related]
28. Developments in Intralesional Therapy for Metastatic Melanoma. Sloot S; Rashid OM; Sarnaik AA; Zager JS Cancer Control; 2016 Jan; 23(1):12-20. PubMed ID: 27009452 [TBL] [Abstract][Full Text] [Related]
29. Intralesional immunotherapy as a strategy to treat melanoma. Nouri N; Garbe C Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656 [TBL] [Abstract][Full Text] [Related]
30. Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha. Vaishampayan U; Abrams J; Darrah D; Jones V; Mitchell MS Clin Cancer Res; 2002 Dec; 8(12):3696-701. PubMed ID: 12473578 [TBL] [Abstract][Full Text] [Related]
32. A role of immunotherapy in metastatic malignant melanoma. Allen T; Gundrajakuppam L Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):182-8. PubMed ID: 22697295 [TBL] [Abstract][Full Text] [Related]
33. Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine. Sondak VK; Sosman JA Semin Cancer Biol; 2003 Dec; 13(6):409-15. PubMed ID: 15001159 [TBL] [Abstract][Full Text] [Related]
35. The role of vaccine therapy in the treatment of melanoma. Lens M Expert Opin Biol Ther; 2008 Mar; 8(3):315-23. PubMed ID: 18294102 [TBL] [Abstract][Full Text] [Related]
36. [Strategies for gene therapy of melanoma]. Dummer R; Davis-Daneshfar A; Döhring C; Döbbeling U; Burg G Hautarzt; 1995 May; 46(5):305-8. PubMed ID: 7607892 [TBL] [Abstract][Full Text] [Related]
37. Intralesional therapy for advanced melanoma: promise and limitation. Agarwala SS Curr Opin Oncol; 2015 Mar; 27(2):151-6. PubMed ID: 25629369 [TBL] [Abstract][Full Text] [Related]
38. Melanoma and immunotherapy. Eggermont AM; Schadendorf D Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602 [TBL] [Abstract][Full Text] [Related]